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Background: The purpose of this study was to investigate the long-term efficacy of tran-
scranial direct current stimulation (tDCS) in the neurorehabilitation of Alzheimer’s disease
(AD).
Methods:Thirty-four AD patients were randomly assigned to three groups: anodal, catho-
dal, and sham tDCS. Stimulation was applied over the left dorsolateral prefrontal cortex for
25 min at 2 mA, daily for 10 days. Each patient was submitted to the following psychome-
tric assessments: mini-mental state examination (MMSE) and Wechsler adult intelligence
scale-third edition at base line, at the end of the 10th sessions and then at 1 and 2 months
after the end of the sessions. Motor cortical excitability and the P300 event-related potential
were assessed at baseline and after the last tDCS session.
Results: Significant treatment group× time interactions were observed for the MMSE and
performance IQ of the WAIS. Post hoc comparisons showed that both anodal and cathodal
tDCS (ctDCS) improved MMSE in contrast to sham tDCS. Whereas, this was only true for
ctDCS in the performance IQ. Remarkably, tDCS also reduced the P300 latency, but had
no effect on motor cortex excitability.
Conclusion: Our findings reveal that repeated sessions of tDCS could not only improve
cognitive function but also reduce the P300 latency, which is known to be pathologically
increased in AD.
Keywords: Alzheimer’s disease, cognitive function, transcranial direct current stimulation, Wechsler Adult Intelli-
gent Scale, cortical excitability, auditory event-related potentials (P300), cortical plasticity
INTRODUCTION
Alzheimer’s disease (AD) is a progressive neurodegenerative dis-
order (Alzheimer’s Association et al., 2011) that causes deficits in
many cognitive activities such as memory, language, and exec-
utive function including working memory, cognitive flexibility
(Monsell, 2003), planning (Chan et al., 2008), and abstract rea-
soning (Bruce and Jeffrey, 2007). AD’s behavioral effects result
from changes in neuronal activity secondary to the disease process
itself. There are changes in modulatory transmitter systems, and
network connectivity while physiological studies have reported
that hyperexcitability of the motor cortex (Di Lazzaro et al., 2004;
Rossini et al., 2007; Khedr et al., 2011) correlates with cognitive
severity (Alagona et al., 2001).
Given the limited efficacy of pharmacological treatments
(Birks, 2006), non-pharmacological approaches in AD are of great
interest. One approach that has been used in several centers
is repetitive transcranial magnetic stimulation (rTMS), a non-
invasive form of brain stimulation that produces after-effects
on cortical excitability thought to involve forms of long-term
potentiation/depression (LTP/LTD) at central synapses. In most
studies, rTMS has been targeted over the dorsolateral prefrontal
cortex (DLPFC), given its recognized role in executive function,
and has been reported to improve memory, language, and execu-
tive functions for several weeks after a period of treatment (Cotelli
et al., 2006, 2008, 2011; Ahmed et al., 2012). Rabey et al. (2013)
combined TMS (over left and right DLPFC, Broca, and Wernicke
areas) with cognitive training (rTMS-COG) on 15 AD patients
in a randomized double-blind, controlled study, and observed an
improvement in memory and learning enhancement.
However, rTMS is a difficult treatment to sham successfully
since real stimulation causes scalp sensations and muscle twitches
that are not present with most forms of sham-rTMS. In more
recent years, however, a second method has attracted substantial
interest, transcranial direct current stimulation (tDCS), which can
modulate cortical excitability and induce effects that outlast the
period of stimulation which, like those after rTMS, are thought to
be due to effects on synaptic long-term potentiation/depression
(Bindman et al., 1962; Gartside, 1968; Karim et al., 2003, 2004).

























































Khedr et al. tDCS and Alzheimer’s disease
tDCS is usually applied using a current of 1–2 mA. Many stud-
ies have shown that tDCS at 1 mA often leads to polarity-specific
effects, with cathodal tDCS (ctDCS) decreasing and anodal tDCS
(atDCS) increasing cortical excitability. However, the duration and
strength of tDCS after-effects depend on duration and intensity
of the applied currents (Nitsche and Paulus, 2000, 2001; Nitsche
et al., 2003; Suemoto et al., 2014; Wiethoff et al., 2014). For exam-
ple, although 2 mA atDCS over motor cortex seems to produce a
slightly longer lasting facilitation of excitability than 1 mA, ctDCS
at 2 mA reverses the “usual” (1 mA) inhibitory effect to facilitation
(Batsikadze et al., 2013). Whether this effect also occurs over other
cortical areas is unknown.
Some studies have investigated the effects of (the presumed
excitatory) atDCS in AD, in which the left temporal cortex (TC)
was targeted because of its role in memory processes, and the
DLPFC because of its role in executive function. Boggio et al.
(2009) found positive effects on visual recognition memory in 10
AD patients after atDCS at 2 mA for 30 min over the left DLPFC.
Another study reported improved word-recognition memory in
10 patients with probable AD based on diagnostic criteria from
the National Institute of Neurological and Communicative Dis-
orders and Stroke and the AD and Related Disorders Associa-
tions (NINCDS–ADRDA) (McKhann et al., 1984), after atDCS at
1.5 mA for 15 min of the temporoparietal areas (Ferrucci et al.,
2008). Finally, enhanced long-term visual recognition memory
for up to 4 weeks after therapy was found after atDCS at 2 mA
over TC bilaterally in 15 AD patients (Boggio et al., 2012). Fur-
thermore, Cotelli et al. (2014) recorded improvement in naming
accuracy after application of atDCS over the left DLPFC with lan-
guage training in 16 patients suffering from primary progressive
aphasia.
We therefore decided to conduct a larger study on 34 patients
with AD, to examine the long-term effects of 2 weeks tDCS over
the left DLPFC on cognitive function in AD. We chose to apply
2 mA tDCS because many positive clinical studies have used this
intensity. However, since both 2 mA atDCS and 2 mA ctDCS are
excitatory on the motor cortex (Batsikadze et al., 2013), we decided
to compare whether one would be more effective than the other in
treating AD. The patients were therefore divided into three groups,
which received either atDCS, ctDCS, or sham tDCS applied over
the DLPFC daily for 10 sessions. Cognitive function was tested
with the Mini-mental state examination (MMSE) (Folstein et al.,
1975) and the Wechsler adult intelligence subscales (WAIS-III)
(Wechsler, 1997). However, since the neurophysiological mecha-
nisms underlying tDCS modulation of cognitive function is not
well understood, we also explored the effects of tDCS on elec-
trophysiological brain activity using the auditory P300 evoked
potential, which has been used as an objective biological marker
of AD (Parra et al., 2012). Finally, since previous work had shown
that AD is associated with increased excitability of motor areas
we also examined possible effects on the motor cortex, reasoning
that treatment for several days might have wide ranging effects on
brain function at a distance from the direct site of stimulation.
METHODS
This trial is reported following 2010 CONSORT guidelines. A
participants’ flow diagram is shown in Figure 1.
PATIENTS
Forty-five consecutive patients with a diagnosis of probable AD
according to the criteria of the National Institute of Neurologi-
cal and Communicative Disorders and Stroke Alzheimer Disease
and Related Disorders Association (NINCDS-ADRDA) (McK-
hann et al., 1984), were recruited from out-patients clinics and
private clinics during the period from October 2011 to September
2012. In all patients, computed tomography scan (CT) or magnetic
resonance imaging (MRI) were obtained to detect the diffuse brain
atrophy and to exclude other causes of dementia.
Exclusion criteria were the following: previous history of stroke,
metabolic disturbance, other major medical illnesses or epilepsy,
and severe forms of dementia. Patients with metallic objects in the
body, or subjected to a craniotomy in the past, were also excluded.
At the time of recruitment, none of the patients were taking choli-
nomimetics, antidepressants, or neuroleptic, sedative-hypnotic
drugs for at least 1 week before the assessment.
The stage of dementia was evaluated by means of the MMSE
(Folstein et al., 1975). Eleven patients were excluded because nine
out of them had severe dementia and two patients refused to
participate in the study. Thus, 34 patients with mild to moder-
ate dementia were included in this study. Dementia was classified
according to the MMSE score as 21–17 for mild, 16–9 for moder-
ate in illiterate patients; these values correspond to the values of
23–19, and 18–11 for mild, and moderate dementia, respectively,
using the full score of 30 points in case of educated patients (Farrag
et al., 1998).
The mean (SD) age was 69.7 (4.8) years ranging from 62 to
79 years and the mean duration of illness was 3.1 (2.1) years rang-
ing from 1 to 10 years. Nineteen males and fifteen females were
including in the study. The mean (SD) total MMSE score of AD
patients was 18.1 (3.3) ranging from 12 to 23, 15 patients had mild
dementia, 19 patients had moderate dementia.
Each patient was evaluated with the MMSE (Folstein et al.,
1975), and WAIS-III (Wechsler, 1997).The WAIS-III provided Per-
formance IQ and Verbal IQ scores with four secondary indices
including: 1. Verbal Comprehension (information, similarities,
and vocabulary). 2. Working Memory (arithmetic and digit span).
3. Perceptual Organization (picture completion, reasoning matrix,
and block design). 4. Processing Speed (digit symbol-coding and
symbol search).
In each subject, the following neurophysiological measures
were also assessed: event-related potentials (P300), resting motor
thresholds (rMT), active motor thresholds (aMT), and cortical
silent periods (CSP). The examiner was blind to the degree of
dementia and the experimental condition. All of the patients
received memantine tablets 10 mg/day for at least 3 months
before starting the study. All participants or their caregivers gave
informed consent before participation in the investigation and
after full explanation of the study protocol, which was approved
by the Local Ethical Committee of Assiut University Hospital.
EVENT-RELATED POTENTIALS (P300)
Event-related potentials were elicited with an auditory discrimi-
nation task paradigm by presenting a series of binaural 2000 Hz
(standard) vs. 1000 Hz (target) tones at 70 dB with a 10 ms
rise/fall and 40 ms plateau time. Tones were presented at a rate
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FIGURE 1 |The flow chart.
of 1.1 per second, with target tones occurring randomly with 0.2
probabilities. The interstimulus interval was 3 s. The participant
was required to distinguish between the two tones by responding to
the target (pressing a button) and not responding to the standard
tone. Evoked potentials were recorded from scalp electrodes placed
at FZ (according to International 10–20 system) and were referred
to linked ears A1/A2. Ground forehead electrode was applied at
Fp1. Filter settings were 0.5 and 70 Hz, analysis time 1 s, sensitiv-
ity 20µV and duration of stimulus 0.1 ms. Separate averages for
target and non-target tones were obtained. Responses to 30 tar-
get and 120 non-target tones were obtained in each trial. Before
recording, subjects were familiarized with the two tones. Automat-
ically the number of errors was measured. The recordings of the
responses were performed with a Nihon Kohden Machine model
9400 (Japan) with silver–silver chloride surface electrodes, applied
at FZ. P300 latency was measured as the major positive peak after
N200, within a range of 250–500 ms. P300 amplitude was mea-
sured peak to peak from the negative component just before P300,
which represents N200, to the maximum positive peak P300.
ELECTROPHYSIOLOGICAL INVESTIGATIONS USING TMS
Subjects sat in a comfortable chair. Electromyographic (EMG)
recordings from the first dorsal interosseous muscle (FDI) of both
hands were acquired with silver–silver chloride surface electrodes,
using a muscle belly-tendon set-up, with a 3 cm diameter circular
ground electrode placed on the wrist. A Nihon Kohden Machine
model 9400 (Japan) was used to collect the signals. EMG para-
meters included a band pass of 20–1000 Hz and a recording time
window of 200 ms. TMS was performed with a commercially avail-
able 90 mm figure-of-eight coil connected to Magstim super rapid
magnetic stimulator (UK).
DETERMINATION OF MOTOR THRESHOLDS
First, we determined the optimal scalp location in both hemi-
spheres from which TMS evoked motor potentials of the greatest
amplitude that could be evoked in the FDI. We used constant
suprathreshold stimulus intensity and moved the figure-of-eight
coil systematically in 1 cm steps to determine the scalp position
from where TMS evoked motor potentials of maximum peak to

























































Khedr et al. tDCS and Alzheimer’s disease
peak amplitude in the target muscle. The coil was positioned tan-
gentially to the scalp and oriented so that the induced electrical
currents would flow approximately perpendicular to the central
sulcus, at a 45 angle from the mid-sagittal line. Single pulse TMS
was then delivered to the optimal location starting at suprathresh-
old intensity and decreasing in steps of 1% of the stimulator
output. The EMG signals were monitored for 200 ms prior to stim-
ulation. The rMT was defined as the minimal intensity required
eliciting motor evoked potentials of 50µV peak to peak amplitude
in five out of ten consecutive trials.
The aMT was determined in the same way while subjects made
a mild contraction of about 10% maximum. aMT was defined
as the minimal intensity required to elicit an MEP larger than
200µV in five of ten consecutive trials. Both the rMT and the
aMT were expressed as a percentage of the magnetic stimulator
output (maximum being equal to 100%). rMT and aMTs were
measured in both hemispheres.
CORTICAL SILENT PERIOD
The duration of the CSP was determined for left hemisphere dur-
ing isometric voluntary contraction of the contralateral FDI. The
participants were asked to perform a 50% maximum voluntary
abduction of the index finger as judged by audio-visual feed-
back. Voluntary contraction started 10 s before TMS. Stimuli were
delivered not closer than one every 15 s to avoid fatigue. Ten mag-
netic stimuli were applied at intensity 130% of rMT. The EMG
traces were rectified and averaged. The length of the CSP (ms)
was determined from the end of the motor evoked potential to the
recurrence of at least 50% of EMG background activity.
All neurophysiological measures were made before the first and
then repeated after the last treatment session.
GROUP ALLOCATIONS: THREE PARALLEL GROUPS
Anodal, cathodal, or sham with a ratio 1:1:1 were placed in serially
numbered opaque closed envelopes. Each patient was given a serial
number from a computer generated randomization table, and was
placed in the appropriate group after opening the corresponding
sealed envelope. The mean age (SD) of each group was 68.5 (7.2),
70.7 (5.4), 67.3 (5.9) years for anodal, cathodal, and sham group,
respectively (p= 0.44) with male/female ratio. 6/5; 8/4; 5/6 for
anodal, cathodal, and sham group, respectively (p= 0.59). There
was no significant difference in the duration of dementia between
groups (p= 0.81) with a mean duration (SD) of 3.0 (2.6), 2.9 (1.9),
and 3.5 (1.7) years for anodal, cathodal, and sham group, respec-
tively (Table 1).The anodal and cathodal groups received tDCS for
25 min at 2 mA daily for 10 consecutive days. The standardized
stimulation localization was over the left DLPFC, at 6 cm anterior
to the left primary motor cortex (M1) parallel to sagittal plane
(George and Post, 2011; Li et al., 2013).
Direct current was delivered with saline soaked electrodes
applied and secured onto the scalp (CX – 6650 Model TRCU –
04A Rolf Schneider Electronics, D-37130 Gleichen, Germany).
The anodal electrode (24 cm2) was placed over the left DLPFC and
the cathodal electrode (100 cm2 used as reference electrode) was
fixed over the contralateral supraorbital region for anodal group.
The electrode polarities were reversed for the cathodal stimulation
group as the cathodal electrode (24 cm2) was placed over the left
DLPFC and the anodal electrode (100 cm2 used as reference elec-
trode) was fixed over the contralateral supraorbital region. A large
reference electrode (100 cm2 compared to 24 cm2 for the func-
tionally effective electrode) was used to reduce the possible effects
of stimulation at that site by reducing the overall current density,
as demonstrated by Nitsche et al. (2007).
For sham tDCS, the placement of the electrodes, current inten-
sity, and ramp time was identical to atDCS stimulation group;
however, the stimulation lasted only for 30 s. The investigator
responsible for delivering tDCS had no contact with the patients.
At the end of the therapy patients were asked whether they
thought they had real tDCS or sham. Three of the real group
and 2 of the sham group thought they had received real stim-
ulation (chi squared test: p< 0.05), indicating that blinding was
effective.
We followed up the patients clinically at the end of the 10th
session (after measuring the cortical excitability) and then at 1
and 2 months after the end of the sessions. We also asked patients
specifically whether they experienced any of the common side
effects of tDCS, such as irritation under the electrodes, headache,
and dizziness.
Table 1 | Demographic and clinical baseline data of the investigated groups.
Demographic and clinical baseline data Anodal group N =11 Cathodal group N =12 Sham group N =11 P value
Sex male/female (19/15) 6/5 8/4 5/6 0.59
Age (years) 68.5±7.2 70.7±5.4 67.3±5.9 0.44
Age of onset (years) 65.5±7.8 68.3±5.9 63.8±5.9 0.27
Duration (years) 3.0±2.6 2.9±1.9 3.5±1.7 0.81
MMSE score 18.4±3.9 18.8±2.9 16.9±2.9 0.36
Dementia degree (mild/moderate) (15/19) 5/6 6/6 4/7 0.80
DM (yes/no) (8/26) 4/7 2/10 2/9 0.47
Hypertension (yes/no) (8/26) 1/10 4/8 3/8 0.36
IHD (yes/no) (2/32) 1/10 0/12 1/10 0.31
Neurological disease (yes/no) 3/8 1/11 0/11 0.50
Parkinsonism 2 1 0
Senile tremors 1 0 0
MMSE score, mini-mental state examination;WAIS-III, Wichsler adult intelligent scale-third edition; DM, diabetes mellitus; IHD, ischemic heart disease.
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The change in MMSE was considered as primary outcome and
changes in WAIS-III subtests and p300 were considered as sec-
ondary outcome. Cortical excitability and P300 were performed
before the 1st tDCS session and repeated immediately after the end
of 10th session for each patient. During the course of the study
the patients did not receive any drug treatment except memantine
10 mg/day. All assessments were performed by a neurologist blind
to the treatment group.
DATA ANALYSIS
All data were analyzed with the aid of the SPSS ver. 16 (http:
//www.spss.com). The results were expressed as mean± SD. Since
the distribution of the data did not differ statistically from normal-
ity, statistical analysis of the scores in each test was performed with
a repeated measures analysis of variance (rmANOVA) with TIME
(pre- and post-tenth session, and then at 1 and 2 months follow-
up) as the within-subject factor, and TREATMENT CONDITION
(anodal, cathodal, and sham tDCS) as the between subject mea-
sure. Effect of gender was also done along the course of treatment.
Greenhouse–Geisser degree of freedom corrections were applied
to correct for the non-sphericity of the data. P< 0.05 was consid-
ered significant for all statistical analysis. Spearman’s correlation
was done between age and percent changes in MMSE (pre-post
3 months× 100/pre-stimulation).
RESULTS
All the patients tolerated tDCS well without any adverse effects
except two patients under active stimulation recorded itching,
headache, and dizziness that were disappear after few hours. Nine-
teen males and fifteen females withe no significant differences
between groups as regards to sex distribution, with P = 0.59. There
were no significant differences between the groups in baseline
demographic and clinical data (age, onset, and duration of illness)
or in the different clinical rating scales (MMSE and WAIS-III total
scores) (see Table 1).
CLINICAL SCORES
Analysis of MMSE: there were main effects of TIME
for each treatment group (P < 0.01 and 0.001 for anodal
and cathodal group, respectively) while no such change
was recorded in sham group (F 1.8= 1.0, P = 0.37). Two
way rmANOVAs on the scores for the MMSE, with
TREATMENT CONDITION(Anodal, Cathodal, and Sham tDCS) and
TIME(baseline, post sessions, 1 month, and 2 months) as main factors
revealed a significant TREATMENT CONDITION×TIME inter-
actions for MMSE (F 3,50= 3.18, P = 0.029), mainly in orienta-
tion (F 3,9= 4.2, P = 0.005, registration (F 4,2= 4.7, P = 0.002),
attention (F 4,0= 4.2, P = 0.004), and Naming objects (F 3,0= 6.8,
P = 0.03) (see Figure 2).
Follow-up comparisons of each treatment group vs.
sham revealed a significant TIME (pre, post, 1 month, and
2 months)×TREATMENT CONDITION interaction for the
comparison of anodal vs. sham tDCS (F 2,52= 3.8, P = 0.04) and
for cathodal vs. sham tDCS (F 2,52= 6.7, P = 0.005). There was no
difference between cathodal and atDCS. We conclude that both
forms of real tDCS improved MMSE score more than sham tDCS.
We also conducted a number of exploratory analyses on subtests
of the MMSE. Patients in the anodal group improved better than
sham group in orientation, registration, attention, and in nam-
ing object (F 1.8= 3.5, P = 0.044, F 1.8= 5.8, P = 0.01, F 2.1= 7.3,
P = 0.002, and F 1.3= 3.8, P = 0.05). No significant changes in the
other subitems of MMSE.
Patients who received ctDCS improved significantly better
than patients receiving sham along the course of the follow-up
in the following tasks: orientation, registration, and attention
(F 2,2= 10.7, P = 0.0001, F 2,2= 4.8, P = 0.01, F 1,8= 4.1, P = 0.02,
respectively).
FIGURE 2 | (A) Illustrates the technique used for transcranial DC stimulation.
Direct current (2 mA) was applied between two, wet sponge-electrodes
placed over the left dorsolateral prefrontal cortex (DLPFC) and the
contralateral supraorbital region. TDCS polarity refers to the prefrontal
electrode, which had a size of 24 cm2, whereas, the reference electrode had a
size of 100 cm2. (B) Depicts the effects of tDCS on the mini-mental state
examination (MMSE). Significant improvements in MMSE were observed in
the anodal (F=6.5, P=0.01) and cathodal group (F=13.8, P<0.001),
whereas no significant changes were observed in the sham group. A
significant TREATMENT CONDITION×TIME interactions for MMSE (0.02).
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Analysis of WAIS-III (Full IQ, Performance and Verbal IQ)
with TREATMENT CONDITION(Anodal, Cathodal, and Sham tDCS)
and TIME(baseline, post sessions, 1 month, and 2 months) as main factors
revealed a significant TREATMENT CONDITION×TIME inter-
action for WAIS performance scores (df= 3.229; F = 2.823;
P = 0.04), but not for the verbal or total WAIS score (df= 4.254,
F = 2.184, P = 0.076 and df= 4.717, F = 1.922, P = 0.105, respec-
tively).
When each treatment group was tested separately against
sham for effects on performance IQ, ANOVAs showed a sig-
nificant TIME×TREATMENT CONDITION interaction when
comparing cathodal vs. sham (F = 5.143, df= 2.123, P = 0.008)
whereas this was not significant for atDCS (F = 1.149, df= 1.315,
P = 0.253). However, there was no significant difference between
anodal and cathodal effects. We conclude that ctDCS improved
performance IQ more than sham tDCS.
Given the marginal significance of the overall ANOVA on verbal
IQ (see above), we performed an exploratory analysis comparing
each treatment group vs. sham. There was no significant TIME
(pre, post, 1 month, and 2 months)×TREATMENT CONDI-
TION interaction for anodal vs. sham tDCS (F = 1.06, df= 1.98,
P = 0.354) or cathodal vs. sham tDCS (F = 2.762, df= 2.127,
P = 0.071). However, it is interesting to note that, as with the per-
formance IQ, there was a tendency for ctDCS to be slightly more
effective than sham.
Effects of tDCS on the secondary indices of WAIS-III
For completeness, the data for the secondary indices are illustrated
in Figure 3. Repeated measures two way ANOVA failed to reveal
any significant GROUP×TIME interactions, suggesting that the
effect of tDCS on WAIS is likely to be relatively small.
The results are depicted in Figures 3 and 4.
Effect of age and gender in relation to changes of different rating
scales
No significant spearman’s correlation between age and percent
changes in MMSE (pre-post 3 months× 100/pre-stimulation);
r = 0.26 and p= 0.1790.
Two way ANOVA Time “pre, post, 1 month, and 3 months”×
gender (male and female) show that; there is no effect of gender
in relation to different rating scales along the course of treatment.
For MMSE; df= 1.5 (48), F = 0.172, and P = 0.78. For verbal IQ
df= 2.3 (65), F = 0.172, and P = 0.188 and for Performance IQ
df= 1.6 (52), F = 1.1, and P = 0.31.
NEUROPHYSIOLOGICAL MEASURES
A two factor rmANOVAs with TREATMENT CONDITION
(Anodal, Cathodal, and Sham tDCS) and TIME(baseline, post sessions) revealed
a significant TREATMENT CONDITION×TIME interaction for
the P300 latency [df= 2 (31), F = 4.25, P = 0.023]. Follow-up
pairwise comparisons showed significant effects of anodal and
ctDCS over sham for the P300 latency [df= 1 (20), F = 5.9, and
P = 0.02 for both], while there was no significant difference in
P300 latency between atDCS and ctDCS (F = 0.7 and P = 0.79).
Final one-way ANOVAs on the time course during each single
intervention showed a significant effect of TIME for both anodal
and ctDCS [df= 1 (10), F = 5.09, P = 0.041, and df= 1(11),
FIGURE 3 | Effects of tDCS on subscales of WAIS-III; vocabulary (A),
information (B), and digit span (C). Vocabulary: significant effect of TIME
in the anodal and cathodal groups (P=0.03, and 0.007, respectively), while
no significant effect of time on sham group (P=0.1). Information: no
significant effect of TIME (pre, post session, 1 month, and 2 months after
end of sessions) in the anodal and sham groups (P=0.4 and 0.6,
respectively), while a significant improvement was found in the cathodal
group (P=0.01). Digit span; no significant effect of TIME (pre, post session,
1 month, and 2 months after end of sessions) in the anodal and sham
groups (P=0.8 and 0.1, respectively), while a significant improvement was
found in the cathodal (P=0.008), with no significant interaction between
groups (time×groups) in any of these subscales.
F = 7.3, 0.03, respectively], while there was no significant change
in the sham condition [df= 1 (10), F = 1.3, P = 0.21]. The P300
amplitude was unaffected by treatment [df= 2 (31), F = 0.05,
P = 0.94].
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FIGURE 4 | Effects of tDCS on subscales of WAIS-III performance (A),
picture completion (B), digit symbol-coding (C), and block design (D). A
significant TREATMENT CONDITION×TIME interactions for WAIS
performance (P =0.04). Picture completion: significant effect of TIME (pre,
post session, 1 month, and 2 months after end of sessions) in the anodal and
cathodal groups group (P=0.02 for each), while no significant improvement
was sham group (P=0.5). Digit symbol-coding: no significant effect of TIME
(pre, post session, 1 month, and 2 months after end of sessions) in the anodal
and sham groups (P=0.6, 0.3, respectively), while a significant improvement
was found in the cathodal group (P=0.03). Block design: no significant effect
of TIME (pre, post session, 1 month, and 2 months after end of sessions) in
the anodal and sham groups (P=0.2, and 0.1, respectively), while a significant
improvement was found in the cathodal group (P=0.0001) with no significant
interaction between groups (time×groups) in any of the three subscales.
Concerning reaction time, there was a marginally signifi-
cant TIME×TREATMENT GROUP interaction with df= 2(28),
F = 2.7, P = 0.06. Exploratory one-way follow-ups of the effect of
time in each group separately showed a each significant reduc-
tion of reaction time only after ctDCS [df= 1 (10), F = 9.4, and
P = 0.01; see Table 2; Figure 5].
Two way repeated measures ANOVAs revealed no signifi-
cant TREATMENT CONDITION×TIME interactions for the
active or rMTs of either left or right hemisphere. There were no
significant changes in silent period (see Table 3).
DISCUSSION
Several recent studies have reported long-lasting, beneficial effects
of high frequency rTMS over the DLPFC for patients with mild
to moderate AD (Cotelli et al., 2006, 2008, 2011; Ahmed et al.,
2012). The current randomized, double-blind, controlled study
evaluated the effects stimulating left DLPFC with a different form
of non-invasive brain stimulation, atDCS/ctDCS. We found that
following 10 sessions of either atDCS or ctDCS followed by an
additional 2 months of maintenance on memantine (10 mg), there
was a significant improvement in the MMSE score in the active
treatment groups, as compared with the sham group. The mean
change was an increase of nearly 2 points immediately after the
last treatment session with a further increase of 2 points at 1
and 2 months follow-up. In comparison, the mean change in
the sham group was an increase of 1 point at the end of treat-
ment, which declined by 0.8 and 0.4 point at 1 and 2 months,
respectively.
The mechanism of the change is probably multifactorial. tDCS
may increase the effectiveness of the cognitive reserve pool that
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P300 latency (mean± sd) in ms
Pre-session 379.8±55.6 395.1±64.2 350.5±60.6 0.02 0.03 0.79 0.023
Post 10th session 336.5±49.3 357.9±62.5 371.2±49.4
P value t -test (pre–post sessions) 0.041* 0.034* 0.21
P300 amplitude (mean± sd) in µv)
Pre-session 10.4±6.5 8.2±3.9 10.7± 4 0.80 0.89 0.96 0.9
Post 10th session 9.9±4.8 7.8±3.1 9.7±5.4
P value t -test (pre–post sessions) 0.79 0.94 0.72
P300 reaction time (mean± sd) in ms
Pre-session 569.9±105.8 557.3±71.8 569.7±109.1 0.42 0.13 0.03 0.064
Post 10th session 585.4±128.8 505±72.8 559.5±136.5
P value t -test (pre–post sessions) 0.54 0.016 1
Values in the pre-session and post 10th session are expressed as mean±SD.
P values are obtained from twowayANOVAswithTREATMENTGROUP(anodal, cathodal, and sham tDCS) as between subject factor andTIME(pre-session and post 10th session) aswithin-subject
factor.
*P<0.05.
FIGURE 5 | P300 event-related potential, upper traces show p300
latencies and amplitudes before session (upper trace) in the
cathodal (left side) and anodal stimulation (right side). Lower
traces show the effect tDCS (post session) on the latencies of p300 on
both groups. There is a shortening in p300 latencies post sessions in
both groups (pre and post sessions for cathodal stimulation; 393 and
362 ms, and pre and post sessions 430 and 406 ms for anodal
stimulation).
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Table 3 | Resting motor thresholds (rMT), active motor thresholds (aMT), and cortical silent period (CSP) from the left hemisphere in pre and
post sessions among the investigated groups.
Anodal group N =11 Cathodal group N =12 Sham group N =11 P value
Resting motor threshold of left hemisphere (% of maximum output)
Pre-session 35.4±7.2 37.8±9.9 32.2±7.1 0.454
Post 10th session 33.9±7.8 36.8±8.6 32.1±7.5
P value paired t -test (pre–post sessions) 0.035 0.2 0.86
Resting motor threshold of right hemisphere (% of maximum output)
Pre-sessions 33.18±4.94 36.83±9.97 32.82±7.56 0.1
Post 10th session 31.91±5.80 34.50±7.53 32.09±7.89
P value paired t -test (pre–post sessions) 0.022 0.021 0.1
Active motor threshold of left hemisphere (% of maximum output)
Pre-session 26.1±7.4 28.5±7.6 27.6±4.6 0.80
Post 10th session 25.4±7.3 27.3±6.3 27.2±4.5
P value paired t -test (pre–post sessions) 0.13 0.39 0.13
Active motor threshold of right hemisphere (% of maximum output)
Pre-sessions 24.64±5.97 26.91±6.61 25.64±5.53 0.4
Post 10th session 22.82±5.78 24.33±5.33 24.73±3.91
P value paired t -test (pre–post sessions) 0.02 0.023 0.203
Cortical silent period (ms)
Pre-session 156.8±38.3 147.3±51.4 130.6±37 0.87
Post 10th session 151.5±37.4 144.8±47.3 128.7±40
P value paired t -test (pre–post sessions) 0.26 0.21 0.17
Values in the pre-session and post 10th session are expressed as mean±SD. P values are obtained from two way ANOVAs with TREATMENT
GROUP(anodal, cathodal, and sham tDCS) as between subject factor andTIME(pre-session and post 10th session) as within-subject factor.
is still operational in mild and moderate AD. This could involve
effects of tDCS on a broad variety of neurotransmitters includ-
ing acetylcholine and dopamine (Kuo et al., 2007; Monte-Silva
et al., 2009), both of which are involved in cognitive function and
behavior. A possible confound is that there is a practice effect on
some of the clinical tests when repeated in short intervals. How-
ever, this is unlikely to be important since although the sham
group improved at the first test point by a minor degree (1 point),
the improvement faded on repeated testing at 1 and 2 months
follow-up assessments.
Interestingly, both atDCS and ctDCS had similar effects.
Although anodal and cathodal stimulation have opposite effects
on motor cortex when applied with an intensity of 1 mA (Nitsche
and Paulus, 2000; Liebetanz et al., 2002), in many therapeutic stud-
ies it is now standard to use 2 mA current, which was why we
used it in the present work. For reasons that are so far unclear,
at 2 mA ctDCS has the same excitatory effect on motor cortex as
atDCS (Batsikadze et al., 2013; Wiethoff et al., 2014). Wiethoff
et al. found that atDCS at 2 mA facilitated MEPs whereas there
was no significant effect of 2 mA ctDCS. However, after two-step
cluster analysis suggested that approximately 50% individuals had
only a minor or no response to tDCS whereas the remainder had a
facilitatory effect to both forms of stimulation. The reasons for this
difference are unknown, and could involve explanations as diverse
as the rates of calcium influx into pyramidal neurons or spread
of effective current to connected brain regions (Batsikadze et al.,
2013). Nevertheless if multiple mechanisms are involved in the
response to ctDCS, then the less likely it is that any single mech-
anism will correlate with the overall after-effects (Wiethoff et al.,
2014). Thus, our data on DLPFC are in line with those targeting the
motor cortex (Nitsche et al., 2003; Batsikadze et al., 2013; Wiethoff
et al., 2014). However, whether other cortical regions follow the
same rule is unclear. For example, Monti et al. (2008) found that
2 mA ctDCS over left fronto-temporal areas significantly improved
the accuracy of picture naming, whereas atDCS failed to induce
any changes. Similarly, You et al. (2011) found that 2 mA ctDCS
over right superior temporal areas induced significantly greater
improvements in auditory verbal comprehension than atDCS or
sham tDCS over left superior temporal areas.
Although stimulation was applied over DLPFC, it is difficult
to predict the distribution of current that reaches the cortex
(Neuling et al., 2012). It depends on factors including current
density, modulation duration, electrode montage, electrode size,
and orientation of the electric field in relation to the anatom-
ical and geometrical features of the cortex. Indeed, widespread
tDCS-induced changes in cortical activity have been demonstrated
in previous neuroimaging studies (Keeser et al., 2011). However,
since there were no effects on excitability of primary motor cortex
in the present study, we think that there was at least partial focality
of stimulation.
It has been argued that WAIS scores are not optimal for assess-
ment of cognitive function of demented patients. Our data would
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be consistent with this since the effect of active tDCS on the WAIS
was relatively minor, with the only significant effect being on the
performance WAIS. Exploratory analysis of the subscale results
suggested that there might be a larger effect of ctDCS than atDCS
but these need further replication in a future studies.
The observed behavioral improvements were complemented
by parallel changes in the P300 component of the ERP, which
has been widely used to study age-related cognitive dysfunc-
tion, because it reflects attentional and memory processes. The
P300 amplitude and latency are also correlated with the amount
of attentional resources devoted to a given task (Wickens et al.,
1983; Kramer and Strayer, 1988; Gonsalvez and Polich, 2002), and
have been associated with superior memory performance (Fabi-
ani et al., 1990; Johnson et al., 2004). P300 is also a measure of
cognitive performance and decision making (Rohrbaugh et al.,
1974; Pirtošek et al., 2009). In the present study, there was sig-
nificant reduction of P300 latency for both forms of treatment
groups as well as a reduced reaction time, only in the cathodal
group. This result suggests the effect of tDCS on attentional and
memory processes may be accompanied by measurable effects
on cognitive event-related potentials. This result supports the
Nakamura-Palacios et al. (2012) finding that tDCS of left DLPFC
increase the mean P3 amplitude in different types of alcoholic
patients.
Recent meta-analyses on the relation between the P300 com-
ponent and AD showed that there is an increase in P300 latency
in elderly patients with AD compared with subjects without the
disease (Pedroso et al., 2012). Moreover, it has recently been
shown that P300 latencies correlate significantly with performance
on the MMSE and the Consortium to Establish a Registery for
Alzheimer’s disease (CERAD), thus it has been argued that the
P300 could be used as a biological marker to indicate impaired
neuropsychological functions in AD patients (Lee et al., 2013).
Our finding that 2 mA ctDCS/atDCS of the DLPFC resulted not
only in cognitive improvements but also in a significant reduc-
tion of the P300 latency in AD patients is therefore of some
clinical relevance. It can be assumed that altered local cortical
excitability in one part of the responsible network influences the
whole neural network associated with cognitive functions beyond
the site of stimulation leading to comparable electrophysiological
effects.
In conclusion, the results of this preliminary study demonstrate
that both atDCS and ctDCS of the left DLPFC at 2 mA can not only
improve cognitive functions, but also reduce the P300 latency in
AD patients. These findings extend the results of previous studies
and open the way for further exploration of the use of brain stim-
ulation in the rehabilitation of AD. Moreover, as far as we know,
this is the first study using tDCS in an Arabic country (Egypt)
demonstrating that with limited research facilities tDCS can be
used as a simple and effective way to modulate cortical excitability
in neuropsychiatric disorders.
Limitations of the study include the small sample size and pos-
sible effects of concurrent depression as well as the use MMSE
and WAIS-III are global measurements and not site-specific for
the DLPFC. In addition, all patients received the NMDA recep-
tor antagonist memantine, which can potentially affect induction
of plasticity with tDCS. Further studies on unmedicated patients
using more specific psychometric tests for assessment of executive
function of DLPFC would help resolve this.
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